Wyeth Q3
This article was originally published in The Tan Sheet
Executive Summary
Advil revenues increased 18% to $178 mil. in the fiscal third quarter, Wyeth announces during an Oct. 18 analysts call. The brand drove Consumer Healthcare sales worldwide up 8% to $715 mil. in Q3; the division was boosted slightly by sales of Centrum, which advanced 1% to $174 mil. during the period, according to Wyeth. "Adding to our brands was a stronger consumer heritage in this business, our new opportunities such as Advil PM and our recently launched Centrum Cardio," the firm says. The company's worldwide net sales grew 9% to $5.6 bil., though net profit fell slightly to $1.15 bil. versus $1.16 bil. in the prior-year quarter, due in part to charges related to productivity initiatives. President and CEO-elect Bernard Poussot made his first presentation during the call since the firm announced he would replace Robert Essner as CEO in January (1"The Tan Sheet" Oct. 1, 2007, In Brief)...
You may also be interested in...
Wyeth names new CEO
Wyeth announced Sept. 27 that Bernard Poussot will assume the position of CEO and president as of Jan. 1, 2008. Poussot will replace Robert Essner, who was elected CEO in May 2001 and became chairman in January 2003. Poussot began his career at Wyeth in 1986, and held positions including executive vice president until January 2007, when he was promoted to president, chief operating officer and vice chairman of Wyeth (1"The Tan Sheet" Jan. 29, 2007, In Brief). Essner will remain in his positions at Wyeth until Poussot's Jan. 1 start-date...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.